Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Osheiza Abdulmalik, PhD
Researcher Research Associate II
Perelman School of Medicine
University of Pennsylvania
Rivella Lab
3615 Civic Center Blvd
Room 316B
Abramson Research Center
Philadelphia, Pennsylvania, United States
Dr. Abdulmalik’s research interests broadly encompass the hemoglobinopathies and red blood cell disorders, with particular focus on sickle cell disease and beta-thalassemia. Though both disorders are consequences of simple genetic mutations, the implications of these mutations are inherently complex, and include significant morbidities, lifelong challenges, reduced quality of life, and early mortality in patients; as well as substantial healthcare burden on families, caregivers, and society in general.
Dr. Abdulmalik’s current research focuses on three modalities of countering disease pathophysiology. The first approach, in tandem with a multidisciplinary team of collaborators, utilizes medicinal chemistry and structural biology to design novel drugs that block the primary pathophysiology of sickle cell disease, i.e., the polymerization of sickle hemoglobin.
Representative Publications:
Crystal structure of carbonmonoxy sickle hemoglobin in R-state conformation
Related Content
-
Nancy Green, MDNancy Green, MD is a pediatric hematolog...
-
University of Illinois HospitalThe Sickle Cell Program at UI Health is ...
-
Yale New Haven HospitalMedical teams at Yale New Haven Hospital...
-
Kenneth R. Peterson, PhDKenneth R. Peterson is the Professor and...
-
MARAC Statement: Health Insurance Coverage for Hematopoietic Stem Cell Transplant for Sickle Cell Disease from HLA-m...Hematopoietic stem cell transplant for s...
-
Health Care Utilization Trajectories and Associated Factors for Transitioning Adolescents/Young Adults with Sickle C...Limited research had explored health car...
-
The Cellie Coping Kit helps sick kids manage the stress of treatmentDesigned by Marsac during her fellowship...